![Paul Stone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Stone
Direttore operativo presso
5AM Venture Management LLC
Profilo
Mr. Paul A. Stone is a Legal Advisor at 5AM Venture Management LLC.
Mr. Stone was previously employed as a Chief Financial Officer & Executive Vice President by IDEAYA Biosciences, Inc., a Chief Patent Counsel & Senior Vice President by Ethos Pharmaceuticals, Inc., a Chief Patent Counsel, SVP & General Counsel by Ilypsa, Inc., a Chief Patent Counsel & Vice President by Symyx Technologies, Inc., and an Attorney by Senniger Powers LLP.
He also served on the board at Homology Medicines, Inc., K2 Therapeutics, Inc., Save the Bay and The Assay Depot, Inc.
He received his undergraduate degree from the University of Wisconsin and a graduate degree from the University of Wisconsin.
Posizioni attive di Paul Stone
| Società | Posizione | Inizio |
|---|---|---|
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Direttore operativo | 26/03/2010 |
Precedenti posizioni note di Paul Stone
| Società | Posizione | Fine |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Direttore Finanziario/CFO | 10/11/2023 |
| Q32 BIO INC. | Direttore/Membro del Consiglio | 01/12/2015 |
| CIDARA THERAPEUTICS | Direttore/Membro del Consiglio | 01/05/2014 |
Ethos Pharmaceuticals, Inc.
 Ethos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide drugs | Consigliere Generale | 01/03/2009 |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | 01/10/2007 |
Formazione di Paul Stone
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
97
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Symyx Technologies, Inc.
 Symyx Technologies, Inc. Packaged SoftwareTechnology Services Develops research technologies and research software | Technology Services |
Ethos Pharmaceuticals, Inc.
Ethos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide drugs | Health Technology |
The Assay Depot, Inc.
 The Assay Depot, Inc. Packaged SoftwareTechnology Services Operates as an AI-powered R&D orchestration platform that enables pharmaceutical and biotech companies | Technology Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
Senniger Powers LLP
 Senniger Powers LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Save the Bay
 Save the Bay Save the Bay is based in Oakland, CA. The company's vision is to make the bay fully swimmable and fishable, accessible to all. Through advocacy, education, and habitat restoration and adaptation work, Save the Bay works to protect and restore the bay for both people and wildlife. The company recognizes the challenges posed by climate change, growing populations, and environmental injustices, and believe that collective efforts are needed to bring about positive change. Save the Bay is a nonprofit organization founded in 1970 that aims to protect and improve Narragansett Bay and its watershed. | |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
